Vanarix

Vanarix is a pioneering biotechnology research company focused on developing innovative cell therapy products. Vanarix is dedicated to advancing regenerative medicine, particularly in the treatment of articular cartilage damage. Their flagship product, Cartibeads, represents a new generation of cell therapy designed to regenerate cartilage tissue effectively.

Located at Avenue Mon-Repos 14, Lausanne, Vaud (fr) 1005, CH, Vanarix is committed to creating high-quality hyaline cartilage mini-grafts that closely resemble native tissue. Cartibeads are bio-engineered cartilage implants made from allogeneic chondrocytes. These implants are designed to self-integrate into cartilage lesions during minimally invasive arthroscopic surgery, facilitating complete tissue regeneration. Vanarix's innovative approach addresses cartilage defects in both traumatic and osteoarthritic joints.

Vanarix aims to set new standards in cartilage repair and regeneration through cutting-edge research and development. With a focus on improving patient outcomes and quality of life, Vanarix is poised to make a significant impact on the field of regenerative medicine. We invite the management of Vanarix to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.